- Home
- SOHO vs TENX Comparison
SOHO vs TENX Comparison
Compare SOHO & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- TENX
- Stock Information
- Founded
- SOHO 2004
- TENX 1967
- Country
- SOHO United States
- TENX United States
- Employees
- SOHO N/A
- TENX N/A
- Industry
- SOHO Real Estate Investment Trusts
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- TENX Health Care
- Exchange
- SOHO Nasdaq
- TENX Nasdaq
- Market Cap
- SOHO 21.5M
- TENX 21.8M
- IPO Year
- SOHO 2004
- TENX N/A
- Fundamental
- Price
- SOHO $0.86
- TENX $6.50
- Analyst Decision
- SOHO Hold
- TENX Strong Buy
- Analyst Count
- SOHO 1
- TENX 4
- Target Price
- SOHO $1.50
- TENX $20.67
- AVG Volume (30 Days)
- SOHO 49.3K
- TENX 36.1K
- Earning Date
- SOHO 03-05-2025
- TENX 11-13-2024
- Dividend Yield
- SOHO N/A
- TENX N/A
- EPS Growth
- SOHO N/A
- TENX N/A
- EPS
- SOHO N/A
- TENX N/A
- Revenue
- SOHO $179,860,606.00
- TENX N/A
- Revenue This Year
- SOHO N/A
- TENX N/A
- Revenue Next Year
- SOHO $0.70
- TENX N/A
- P/E Ratio
- SOHO N/A
- TENX N/A
- Revenue Growth
- SOHO 3.98
- TENX N/A
- 52 Week Low
- SOHO $0.81
- TENX $2.77
- 52 Week High
- SOHO $1.54
- TENX $21.46
- Technical
- Relative Strength Index (RSI)
- SOHO 37.81
- TENX 60.16
- Support Level
- SOHO $0.81
- TENX $6.20
- Resistance Level
- SOHO $0.93
- TENX $6.73
- Average True Range (ATR)
- SOHO 0.06
- TENX 0.36
- MACD
- SOHO -0.00
- TENX -0.02
- Stochastic Oscillator
- SOHO 28.37
- TENX 72.05
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.